Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Apr 29;31(5):2508-2526.
doi: 10.3390/curroncol31050188.

Impact of PET/CT Imaging with FDG in Locally Advanced Cervical Carcinoma-A Literature Review

Ottó Molnar  1 , Oreste Mihai Straciuc  1   2 , Simona Mihuțiu  3   4 , Liviu Lazăr  1   3   5
Affiliations
Review

Impact of PET/CT Imaging with FDG in Locally Advanced Cervical Carcinoma-A Literature Review

Ottó Molnar et al. Curr Oncol. .

Abstract

Positron emission tomography (PET) and computed tomography (CT) have evolved as a pivotal diagnostic modality in the field of oncology. With its increasing application in staging and ready availability, it becomes imperative for committed radiation oncologists to possess a complete analysis and understanding of integration of molecular imaging, which can be helpful for radiation planning, while also acknowledging its possible limitations and challenges. A significant obstacle lies in the synthesis and design of tumor-specific bmolecules for diagnosing and treating cancer. The utilization of radiation in medical biochemistry and biotechnology, encompassing diagnosis, therapy, and control of biological systems, is encapsulated under the umbrella term "nuclear medicine". Notably, the application of various radioisotopes in pharmaceutics has garnered significant attention, particularly in the realm of delivery systems for drugs, DNA, and imaging agents. The present article provides a comprehensive review of use of novel techniques PET and CT with major positron-emitting radiopharmaceuticals currently in progress or utilized in clinical practice with their integration into imaging and radiation therapy.

Keywords: FDG; PET; cervical cancer; computed tomography; diagnostics; follow up; oncology; radiopharmaceuticals; screening; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2017. CA Cancer J. Clin. 2017;67:7–30. doi: 10.3322/caac.21387. - DOI - PubMed
    1. Chauhan R., Trivedi V., Rani R., Singh U., Singh K. Pre-treatment hematological parameters as a cost effective predictive marker for response to concurrent chemo radiation in locally advanced cervical cancer. Cancer Treat. Res. Commun. 2022;31:100539. doi: 10.1016/j.ctarc.2022.100539. - DOI - PubMed
    1. Bianchi T., Grassi T., Di Martino G., Negri S., Trezzi G., Fruscio R., Landoni F. Low-Volume Metastases in Cervical Cancer: Does Size Matter? Cancers. 2024;16:1107. doi: 10.3390/cancers16061107. - DOI - PMC - PubMed
    1. Schilderm J.M., Stehman F.B. Stage Ia-IIa cancer of the cervix. Cancer J. 2003;9:395–403. doi: 10.1097/00130404-200309000-00010. - DOI - PubMed
    1. Huang H., Feng Y.L., Wan T., Zhang Y.N., Cao X.P., Huang Y.W., Xiong Y., Huang X. Effectiveness of Sequential Chemoradiation vs Concurrent Chemoradiation or Radiation Alone in Adjuvant Treatment After Hysterectomy for Cervical Cancer: The STARS Phase 3 Randomized Clinical Trial. JAMA Oncol. 2021;7:361–369. doi: 10.1001/jamaoncol.2020.7168. - DOI - PMC - PubMed

MeSH terms

Substances